Explaining the slow transition of child-appropriate dosage formulations from the global to national level in the context of Uganda: a qualitative study

Xavier Nsabagasani1 Child Health and Development Center, College of Health Sciences,Makerere University,P.O. Box 6717KampalaUganda.Correspondence[email protected]

Ebba Hansen2 Section for Social and Clinical Pharmacy, Department of Pharmacy,Faculty of Health and Medical Sciences University of Copenhagen,CopenhagenDenmark.

Anthony Mbonye3 Ministry of Health Uganda and Department of Health.Uganda Christian University,KampalaUganda.

Freddie Ssengooba4 School of Public Health, College of Health Sciences,Makerere University,KampalaUganda.

Herbert Muyinda1 Child Health and Development Center, College of Health Sciences,Makerere University,P.O. Box 6717KampalaUganda.

James Mugisha1 Child Health and Development Center, College of Health Sciences,Makerere University,P.O. Box 6717KampalaUganda.

Jasper Ogwal-Okeng5 Departments of Pharmacology and Therapeutics,Gulu University,GuluUganda.

show all

Explaining the slow transition of child-appropriate dosage formulations from the global to national level in the context of Uganda: a qualitative study

Table 1 Categories of informants and their institutions

Table 2 Stakeholder Perspectives about child-appropriate medicines

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Explaining the slow transition of child-appropriate dosage formulations from the global to national level in the context of Uganda: a qualitative study

Figures & data

Table 1 Categories of informants and their institutions

Table 2 Stakeholder Perspectives about child-appropriate medicines

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date